Career Center
Job Seekers, Welcome to Regulatory Career Connections
Search Filters
Use this area to filter your search results. Each filter option allows for multiple selections.
Featured! Featured!
Featured! Featured!
US FOOD AND DRUG ADMINISTRATION, OFFICE OF REGULATORY AFFAIRS
United States - Nationwide
NEW! NEW!
NEW! NEW!
NEW! NEW!
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois
Loading... Please wait.
Director, Global Regulatory Strategy and Development
Company Description Angion is a clinical stage biopharmaceutical company focused on acute kidney injury, a potentially life-threatening condition without therapeutic options. Our lead clinical asset, ANG-3777, is engineered to activate the HGF/c-MET pathway, an important mechanism in organ repair. Angion is developing ANG-3777 to meet the high unmet medical need of acute kidney injury resulting from kidney transplantation and from cardiac surgery. We are currently conducting Phase 2 and Phase 3 clinical trials with improvement in kidney function as an endpoint. Angion’s robust pipeline includes ANG-3070, an oral small molecule in development as a potential treatment for fi
Loading. Please wait.
Powered By
For assistance please call 888.491.8833 or e-mail candidatesupport@naylor.com